Novel therapeutic targets in rheumatoid arthritis

Rheumatoid arthritis (RA) is the most common chronic systemic autoimmune disease worldwide. Although incurable, there are available therapies to effectively control the disease activity and minimize the joint damage. Numerous cytokines, enzymes and other forms of proteins have been implicated in...

Full description

Bibliographic Details
Main Author: Sakthiswary Rajalingham
Format: Article
Language:English
Published: Pusat Perubatan Universiti Kebangsaan Malaysia 2018
Online Access:http://journalarticle.ukm.my/20196/
http://journalarticle.ukm.my/20196/1/3_ms0205_pdf_11731.pdf
_version_ 1848815039410077696
author Sakthiswary Rajalingham,
author_facet Sakthiswary Rajalingham,
author_sort Sakthiswary Rajalingham,
building UKM Institutional Repository
collection Online Access
description Rheumatoid arthritis (RA) is the most common chronic systemic autoimmune disease worldwide. Although incurable, there are available therapies to effectively control the disease activity and minimize the joint damage. Numerous cytokines, enzymes and other forms of proteins have been implicated in the disease process of RA. In general, pharmacological therapies in RA target cytokine pathways. Despite a wide variety of disease modifying antirheumatic drugs (DMARD), a significant proportion of patients remain refractory to the available therapies. Hence, the search for newer drugs with different modes of actions is an ongoing process. The present review aimed to explore novel therapeutic targets in RA based on data from the literature. Inhibitors of spleen tyrosine kinase, choline kinase, galectin 3 and hypoxia-inducible factor may have a promising role in thetreatment of RA. Besides, cell based therapies which may enhance the levels of systemic tristetraprolin could be beneficial in RA.
first_indexed 2025-11-15T00:43:38Z
format Article
id oai:generic.eprints.org:20196
institution Universiti Kebangasaan Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T00:43:38Z
publishDate 2018
publisher Pusat Perubatan Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling oai:generic.eprints.org:201962022-10-21T08:05:58Z http://journalarticle.ukm.my/20196/ Novel therapeutic targets in rheumatoid arthritis Sakthiswary Rajalingham, Rheumatoid arthritis (RA) is the most common chronic systemic autoimmune disease worldwide. Although incurable, there are available therapies to effectively control the disease activity and minimize the joint damage. Numerous cytokines, enzymes and other forms of proteins have been implicated in the disease process of RA. In general, pharmacological therapies in RA target cytokine pathways. Despite a wide variety of disease modifying antirheumatic drugs (DMARD), a significant proportion of patients remain refractory to the available therapies. Hence, the search for newer drugs with different modes of actions is an ongoing process. The present review aimed to explore novel therapeutic targets in RA based on data from the literature. Inhibitors of spleen tyrosine kinase, choline kinase, galectin 3 and hypoxia-inducible factor may have a promising role in thetreatment of RA. Besides, cell based therapies which may enhance the levels of systemic tristetraprolin could be beneficial in RA. Pusat Perubatan Universiti Kebangsaan Malaysia 2018 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/20196/1/3_ms0205_pdf_11731.pdf Sakthiswary Rajalingham, (2018) Novel therapeutic targets in rheumatoid arthritis. Medicine & Health, 13 (1). pp. 12-19. ISSN 2289-5728 https://www.medicineandhealthukm.com/toc/13/1
spellingShingle Sakthiswary Rajalingham,
Novel therapeutic targets in rheumatoid arthritis
title Novel therapeutic targets in rheumatoid arthritis
title_full Novel therapeutic targets in rheumatoid arthritis
title_fullStr Novel therapeutic targets in rheumatoid arthritis
title_full_unstemmed Novel therapeutic targets in rheumatoid arthritis
title_short Novel therapeutic targets in rheumatoid arthritis
title_sort novel therapeutic targets in rheumatoid arthritis
url http://journalarticle.ukm.my/20196/
http://journalarticle.ukm.my/20196/
http://journalarticle.ukm.my/20196/1/3_ms0205_pdf_11731.pdf